Skip to main content
. 2017 Oct 17;36:146. doi: 10.1186/s13046-017-0610-5

Fig. 1.

Fig. 1

PAK5 correlates with a worse prognosis in breast cancer patients. a Representative images of PAK5 and p65 immunohistochemical staining in human breast cancer. Magnification × 400 for a. b PAK5 expression staining was higher in BCTs than in paired adjacent NTs. c p65 expression staining was higher in BCTs than in paired adjacent NTs. d High PAK5 expression correlated with a poorer 5-year overall cumulative survival for 129 breast cancer patients (P = 0.0192, log-rank test). e High p65 expression did not correlate with 5-year overall cumulative survival for 119 breast cancer patients (P = 0.1933, log-rank test)